Clinical Trial Detail

NCT ID NCT02155647
Title Avelumab in Subjects With Merkel Cell Carcinoma (JAVELIN Merkel 200)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements no
Sponsors EMD Serono
Indications

Merkel cell carcinoma

Therapies

Avelumab

Age Groups: adult

No variant requirements are available.